Eight bets in, Spain's Ysios officially ties a bow around €216M fund
Having played a part in pioneering biotech venture investing in Spain, Ysios BioFund has closed its third and largest fund to keep pushing the envelope in Europe — and also the US.
The €216 million ($264 million) fund exceeded their initial target, said managing partner Joël Jean-Mairet, thanks to enthusiastic backers such as the European Investment Fund.
As much as 60% of the portfolio of Ysios BioFund III is already in place, with eight investments made over the past year out of the planned 15 — each of which could get up to €20 million depending on the stage.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.